Genital Diseases, Female Clinical Trial
Official title:
Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy : A Prospective, Randomized, Controlled Study
- Indication: Benign tumors of ovary(mature teratoma, mucinous cystadenoma, serous
cystadenoma)
- Intervention: Device ( Test group : Guardix-FL, Control group : Interceed)
- Primary Outcome Measure : Anti-adhesion Rate
- Assessment : Operative Day(Visit 2), Post-Operative Day+7days(Vist 3), Post-Operative
Day+4weeks(Visit4), Post-Operative Day+5weeks(Visit 5)
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04566952 -
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
|
Phase 2 | |
Completed |
NCT03562897 -
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer
|
Phase 2 | |
Completed |
NCT01460979 -
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma
|
Phase 2 | |
Completed |
NCT01456962 -
Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
|
N/A | |
Completed |
NCT00050414 -
A Study of Trabectedin in Patients With Advanced Ovarian Cancer
|
Phase 2 | |
Completed |
NCT01526668 -
Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy
|
N/A | |
Recruiting |
NCT04556071 -
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer
|
Phase 2 | |
Completed |
NCT01462890 -
Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer
|
Phase 3 | |
Completed |
NCT01523652 -
Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients
|
N/A | |
Recruiting |
NCT06134596 -
Correlation of Clitoral Hood and Labia Minora Measurements and Female Genital Self Image Scale (FGSIS) Scores in Women
|
||
Completed |
NCT02747641 -
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
|
N/A | |
Completed |
NCT00365716 -
Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)
|
Phase 2 | |
Completed |
NCT03677336 -
Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI
|
Phase 4 | |
Completed |
NCT02698527 -
The Effect of Buffered Lidocaine Versus Nonbuffered Lidocaine on Pain Scores During Infiltration for Vulvar Biopsies
|
N/A | |
Not yet recruiting |
NCT04807166 -
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
|
Phase 2 | |
Completed |
NCT04858919 -
Transrectal and 3D Transabdominal Ultrasound Compared to Vaginoscopy in Diagnosing Virgins With Genital Lesions
|
N/A | |
Completed |
NCT01628432 -
Effect of Salpingectomy During Conservative Hysterectomy
|
N/A | |
Active, not recruiting |
NCT01271400 -
LANDA Embryo Freezing Technique.
|
N/A | |
Completed |
NCT02642835 -
A Long Term Follow up of Anterior Meshes for Recurrent Prolapse
|
||
Recruiting |
NCT04061967 -
SMS-based Summons in Cervical Screening
|
N/A |